Research ArticleResearch

Cleaning Validation for Residual Estimation of Mometasone Furoate on Stainless-Steel Surface of Pharmaceutical Manufacturing Equipment Using a UHPLC-UV Method

Ana Silva Coelho, Raquel Gregorio Arribada and Eduardo Burgarelli Lages
PDA Journal of Pharmaceutical Science and Technology January 2020, 74 (1) 41-48; DOI: https://doi.org/10.5731/pdajpst.2018.009712

References

  1. 1.↵
    1. Pawar H. A.,
    2. Banerjee N. D.,
    3. Pawar S.,
    4. Pawar P.
    Current Perspectives on Cleaning Validation in Pharmaceutical Industry: A Scientific and Risk Based Approach. Int. J. Pharm. Phytopharm. Res. 2011, 1 (1), 8–16.
    OpenUrl
  2. 2.↵
    Federal Government of Brazil. Agência Nacional de Vigilância Sanitária. ANVISA. Resolução RDC n. 17, 16 de Abril de 2010. Brasília: Diário Oficial da União 2010.
  3. 3.↵
    Government of Canada. Guidance Document: Cleaning Validation Guidelines. Health Products and Food Branch Guide-0028, Minister of Public Works and Government Services: Ottawa, Ontario, 2007.
  4. 4.↵
    International Conference for Harmonisation. Quality Guideline Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. ICH: Geneva, 2000.
  5. 5.↵
    1. Porto L. V. F. M.,
    2. Fukumori N. T. O.,
    3. Matsuda M. M. N.
    Determination of Worst Case for Cleaning Validation of Equipment Used in the Radiopharmaceutical Production of Lyophilized Reagents for 99mTc Labeling. Braz. J. Pharm. Sci. 2016, 52 (1), 105–112.
    OpenUrl
  6. 6.↵
    U.S. Food and Drug Administration. Guidance for Industry Q7A: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services: Rockville, MD, 2001.
  7. 7.↵
    1. Dong M. W.,
    2. Zhang K.
    Ultra-High-Pressure Liquid Chromatography (UHPLC) in Method Development. TrAC, Trends Anal. Chem. 2014, 63, 21–30.
    OpenUrl
  8. 8.↵
    1. Walter T. H.,
    2. Andrews R. W.
    Recent Innovations in UHPLC Columns and Instrumentation. TrAC, Trends Anal. Chem. 2014, 63, 14–20.
    OpenUrl
  9. 9.↵
    1. Gumustas M.,
    2. Kurbanoglu S.,
    3. Uslu B.,
    4. Ozkan S. A.
    UPLC versus HPLC on Drug Analysis: advantageous, Applications and Their Validation Parameters. Chromatographia 2013, 76 (21–22), 1365–1427.
    OpenUrlCrossRefWeb of Science
  10. 10.↵
    1. D'Urzo A.
    Mometasone Furoate Dry-Powder Inhaler for the Control of Persistent Asthma. Expert Opin. Pharmacother. 2007, 8 (16), 2871–2884.
    OpenUrlPubMed
  11. 11.↵
    1. Onrust S. V.,
    2. Lamb H. M.
    Mometasone Furoate: A Review of Its Intranasal Use in Allergic Rhinitis. Drugs 1998, 56 (4), 725–745.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Zitt M.,
    2. Kosoglou T.,
    3. Hubbell J.
    Mometasone Furoate Nasal Spray: A Review of Safety and Systemic Effects. Drug Saf. 2007, 30 (4), 317–326.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    British Pharmacopoeia Commission. British Pharmacopoeia, Volume II, Monographs: Medicinal and Pharmaceutical Substances, Mometasone furoate. BPC: London, 2018.
  14. 14.↵
    1. Sayed R. A.,
    2. El-Masri M. M.,
    3. Hassan W. S.,
    4. El-Mammli M. Y.,
    5. Shalaby A.
    Validated Stability-Indicating Methods for Determination of Mometasone Furoate in Presence of Its Alkaline Degradation Product. J. Chromatogr. Sci. 2018, 56 (3), 254–261.
    OpenUrl
  15. 15.↵
    U.S. Pharmacopeial Convention. In USP 41–NF 36, Volume 2, Mometasone furoate monograph. USP: Rockville, MD, 2018.
  16. 16.↵
    1. El-Bagary R. I.,
    2. Fouad M. A.,
    3. El-Shal M. A.,
    4. Tolba E. H.
    Forced Degradation of Mometasone Furoate and Development of Two RP-HPLC Methods for Its Determination with Formoterol Fumarate or Salicylic Acid. Arabian J. Chem. 2016, 9 (3), 493–505.
    OpenUrl
  17. 17.↵
    1. Merey H. A.,
    2. El-Mosallamy S. S.,
    3. Hassan N. Y.,
    4. El-Zeany B. A.
    Validated Chromatographic Methods for the Simultaneous Determination of Mometasone Furoate and Formoterol Fumarate Dihydrate in a Combined Dosage Form. Bull. Fac. Pharm. (Cairo Univ.) 2016, 54 (1), 99–106.
    OpenUrl
  18. 18.↵
    1. Youssef R. M.,
    2. Korany M. A.,
    3. Afify M. A.
    Development of a Stability Indicating HPLC-DAD Method for the Simultaneous Determination of Mometasone Furoate and Salicylic Acid in an Ointment Matrix. Anal. Methods 2014, 6 (10), 3410–3419.
    OpenUrl
  19. 19.↵
    1. Ourique A. F.,
    2. Contri R. V.,
    3. Guterres S. S.,
    4. Beck R. C. R.,
    5. Pohlmann A. R.,
    6. Melero A.,
    7. Schaefer U. F.
    Set-up of a Method Using LC-UV to Assay Mometasone Furoate in Pharmaceutical Dosage Forms. Quím. Nova 2012, 35 (4), 818–821.
    OpenUrl
  20. 20.↵
    1. Shaikh S.,
    2. Muneera M. S.,
    3. Thusleem O. A.,
    4. Tahir M.,
    5. Kondaguli A. V.
    A Simple RP-HPLC Method for the Simultaneous Quantitation of Chlorocresol, Mometasone Furoate and Fusidic Acid in Creams. J. Chromatogr. Sci. 2009, 47 (2), 178–183.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Surti N.,
    2. Naik S.,
    3. Bagchi T.,
    4. Dwarkanath B. S.,
    5. Misra A.
    Intracellular Delivery of Nanoparticles of an Antiasthmatic Drug. AAPS PharmSciTech 2008, 9 (1), 217–223.
    OpenUrlPubMed
  22. 22.↵
    1. Sahasranaman S.,
    2. Issar M.,
    3. Hochhaus G.
    Metabolism of Mometasone Furoate and Biological Activity of the Metabolites. Drug Metab. Dispos. 2006, 34 (2), 225–233.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Valotis A.,
    2. Neukam K.,
    3. Elert O.,
    4. Högger P.
    Human Receptor Kinetics, Tissue Binding Affinity, and Stability of Mometasone Furoate. J. Pharm. Sci. 2004, 93 (5), 1337–1350.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Teng X. W.,
    2. Foe K.,
    3. Brown K. F.,
    4. Cutler D. J.,
    5. Davies N. M.
    High-Performance Liquid Chromatographic Analysis of Mometasone Furoate and Its Degradation Products. J. Pharm. Biomed. Anal. 2001, 26 (2), 313–319.
    OpenUrlPubMed
  25. 25.↵
    1. Forsatz B.,
    2. Snow N. H.
    HPLC with Charged Aerosol Detection for Pharmaceutical Cleaning Validation. LCGC North Am. 2008, 25, 960–968.
    OpenUrl
  26. 26.↵
    Federal Government of Brazil. Agência Nacional de Vigilância Sanitária. ANVISA. RDC n. 166, 24 de Julho de 2017. Brasília: Diário Oficial da União 2017.
  27. 27.↵
    International Conference for Harmonisation. Quality Guideline Q2(R1):Validation of Analytical Procedures: Text and Methodology. ICH: Geneva, 2005.
  28. 28.↵
    AOAC Official Methods of Analysis. Appendix F: Guidelines for Standard Method Performance Requirements. AOAC International: Rockville, MD, 2016
  29. 29.↵
    1. de Souza S. V. C.,
    2. Junqueira R. G.
    A Procedure to Assess Linearity by Ordinary Least Squares Method. Anal. Chim. Acta 2005, 552 (1–2), 25–35.
    OpenUrl
  30. 30.↵
    1. Shapiro S. S.,
    2. Wilk M. B.
    An Analysis of Variance Test for Normality (Complete Samples). Biometrika 1965, 52 (3–4), 591–611.
    OpenUrlCrossRefWeb of Science
  31. 31.↵
    1. Cochran W. G.
    The Distribution of the Largest of a Set of Estimated Variances as a Fraction of Their Total. Ann. Hum. Genet. 1941, 11 (1), 47–52.
    OpenUrl
Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Cleaning Validation for Residual Estimation of Mometasone Furoate on Stainless-Steel Surface of Pharmaceutical Manufacturing Equipment Using a UHPLC-UV Method
Ana Silva Coelho, Raquel Gregorio Arribada, Eduardo Burgarelli Lages
PDA Journal of Pharmaceutical Science and Technology Jan 2020, 74 (1) 41-48; DOI: 10.5731/pdajpst.2018.009712
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords